VAX102 (M2e-flagellin) Universal Influenza Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VAX102 (M2e-flagellin) Universal Influenza Vaccine, covering 2011-08-22 to 2011-08-22. Get the full timeline:
Most recent: Clinical Trial Update: Comparative Safety and Immunogenicity of 1.0 µg Intramuscular (i.m.) and 2.0 µg Subcutaneous (s.c.) Dosing With VAX102 (M2e-flagellin) Universal Influenza Vaccine in Healthy Adults [Phase 1, Phase 2]